Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03485794 · ClinicalTrials.gov registry record

Collection of Blood in Studying Metabolites in Patients With Prostate Cancer

A clinical trial, sponsored by University of Southern California.

Terminated
Registry status
10
Enrollment target

NCT03485794 is a clinical trial that was terminated before completion, run by University of Southern California. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03485794 was terminated before completion, sponsored by University of Southern California.

TERMINATED
Registry status
10 participants
Enrollment target

Study Summary

This pilot research trial utilizes the collection of blood in studying metabolites in patients with prostate cancer. Metabolites are the small molecule products of cellular metabolism that are produced naturally in all living cells. Collecting blood in order to study metabolites may help doctors monitor and treat prostate cancer more effectively.

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Laboratory Biomarker Analysis

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2017-11-14
Est. Completion 2024-01-02

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT03485794

The ClinicalTrials.gov registry entry for NCT03485794 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Biospecimen Collection is the first listed.

NCT03485794 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03485794 about?

NCT03485794 is a clinical study titled "Collection of Blood in Studying Metabolites in Patients With Prostate Cancer". This pilot research trial utilizes the collection of blood in studying metabolites in patients with prostate cancer. Metabolites are the small molecule products of cellular metabolism that are produced naturally in all living cells. Collecting blood in order to study metabolites may help doctors mon...

What is the current status of trial NCT03485794?

This trial is currently terminated. The enrollment target is 10 participants. The study started on 2017-11-14. Estimated completion is 2024-01-02.

What interventions are being tested in trial NCT03485794?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Laboratory Biomarker Analysis (OTHER).

Who is sponsoring clinical trial NCT03485794?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.